Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Dave, IN
Ashish Dave, Ahmedabad, Gujarat IN
| Patent application number | Description | Published |
|---|---|---|
| 20090287616 | NON NETWORK CASHLESS HEALTH INSURANCE METHOD - This method enables the patients to get the best medical treatment that they desire, entitle and deserve according to their will without worrying about cash payments and make them hassle free of reimbursement problems. The insured gives power of attorney to the non-net work hospital or doctor to submit claim, undertake necessary procedure including legal one if required, settle the dispute related to the claim if one such arises, appoint the agent or representative to carry out claim related procedures and assigns the benefits related to the particular claim so that the insurance company or third party administrator company has to pay the claimed amount directly to the said non-network hospital or doctor. | 11-19-2009 |
Bhavesh Dave, Maharashtra IN
| Patent application number | Description | Published |
|---|---|---|
| 20100310493 | ACETAMIDE DERIVATIVES AS GLUCOKINASE ACTIVATORS, THEIR PROCESS AND MEDICINAL APPLICATION - Acetamide derivatives, their stereoisomers, tautomers, prodrugs, pharmaceutically acceptable salts, polymorphs, solvates and formulations thereof for the prophylaxis, management, treatment, control of progression, or adjunct treatment of diseases and/or medical conditions where the activation of glucokinase would be beneficial, are disclosed. | 12-09-2010 |
Bhavesh Dave, Bangalore IN
| Patent application number | Description | Published |
|---|---|---|
| 20100144772 | 2,2,2-TRI-SUBSTITUTED ACETAMIDE DERIVATIVES AS GLUCOKINASE ACTIVATORS, THEIR PROCESS AND PHARMACEUTICAL APPLICATION - Compounds of the present disclosure are 2,2,2-tri-substituted acetamide derivatives of formula (I), its polymorphs, stereoisomers, prodrugs, solvates, pharmaceutically acceptable salts and formulations thereof, useful as Glucokinase activator. Processes of their preparation are also described in the disclosure. The disclosure also describes method to characterize partial glucokinase activators. | 06-10-2010 |
Kinjal Dave, Vinayaka Nagar IN
| Patent application number | Description | Published |
|---|---|---|
| 20100180085 | HANDLING OF MEMORY ACCESS REQUESTS TO SHARED MEMORY IN A DATA PROCESSING APPARATUS - A data processing apparatus and method are provided for handling memory access requests to shared memory. The data processing apparatus has a plurality of processing units, at least one of which is configured to be switchable between an active power state and a dormant power state. The processing units share a memory, and at least one local storage unit is configured to store a local copy of a data item stored in the memory for access by an associated processing unit. A snoop control unit is configured to monitor memory access requests issued by the processing units and to store in the snoop control unit indications of local copies of data items stored in each local storage unit. When a memory access request for a requested data item is issued by one processing unit, if the snoop control unit has a stored indication that a local storage unit belonging to another dormant processing unit has a local copy of that data storage item and a cache coherency protocol required that the local copy of the requested data item stores in the local storage unit associated with the other processing unit be invalidated, the snoop control unit stores a marker indicating that that other local copy should later be invalidated. This approach ensures that the correct behaviour according to a cache coherency protocol for a shared memory is carried out, without losing the benefits of being able to put one of the processors of the multi-processor system into a dormant power state and avoiding the latency of repeated power state switching. | 07-15-2010 |
Mayank G. Dave, Gujarat IN
| Patent application number | Description | Published |
|---|---|---|
| 20110003846 | POLYMORPH AND AMORPHOUS FORM OF (S)-(+)-CLOPIDOGREL BISULFATE - The present invention relates to new polymorphs of S-(+)-Clopidogrel bisulfate and a process for preparing the same. | 01-06-2011 |
Mayank Ghanshyambhai Dave, Ahmedabad IN
| Patent application number | Description | Published |
|---|---|---|
| 20100016595 | PROCESS FOR PREPARING (S)-(+)-CLOPIDOGREL BASE AND ITS SALTS - Processes for the preparation of Methyl (+)-(S)-(2-chlorophenyl)-(6,7dihydro-4H-thieno[3,2-c]pyridin-5-yl)acetate [Clopidogrel base, (I)] and their various pharmaceutically acceptable salts. | 01-21-2010 |
| 20100081824 | Processes For the preparation of different forms of (S)-(+)-Clopidogrel besylate - Improved processes for the preparation of different forms of (S)-(+)-Clopidogrel besylate, pharmaceutical compositions containing them and their use in medicine. | 04-01-2010 |
| 20110213149 | PROCESS FOR PREPARATION OF (2R)-4-OXO-4-[3- (TRIFLUOROMETHYL)-5,6-DIHYDRO [1,2,4]-TRIAZOLO[4,3-A]PYRAZIN- 7(8H)-YL]-L-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE & NEW IMPURITIES IN PREPARATION THEREOF - The present invention relates to synthesis of β-amino acid derivatives of formula (I) and its salts of formula (Ia) by a novel process. The process comprises the reduction of a protected or unprotected prochiral β-amino acrylic acid or derivative there of, by using borane containing reducing agents at atmospheric pressure. The resulting racemic β-amino compound is resolved to a pure stereoisomer of formula (I), specifically to (2R)-4-oxo-4-[3-Ctrifluoromethyl)-5,6-dihydrol[1,2,4]triazolo[4,3-alpyrazin-7(8H)-yl]-1-(2,4,4-trifluorophenyl)butan-2-amine. In an embodiment the invention disclosed polymorphic forms of formula (I), phosphate salt of formula (I) and also a Dibenzoyl-L-tartaric acid salt of formula (I). | 09-01-2011 |
Mayank Ghanshyambhai Dave, Gujarat IN
| Patent application number | Description | Published |
|---|---|---|
| 20080234323 | Amorphous and Three Crystalline Forms of Rimonabant Hydrochloride - The present invention describes novel forms of Rimonabant hydrochloride, processes for their preparation and pharmaceutical compositions containing them. Thus, the present invention discloses three new crystalline forms designated as Form II, Form III and Form IV of Rimonabant hydrochloride and novel amorphous forms of the salt. | 09-25-2008 |
| 20090221827 | PROCESSES FOR THE PREPARATION OF DIFFERENT FORMS OF (S)-(+)-CLOPIDOGREL BESYLATE - Disclosed herein are the improved processes for the preparation of different forms of (S)-(+)-Clopidogrel besylate, pharmaceutical compositions containing them and their use in medicine. | 09-03-2009 |
| 20100197923 | SALTS OF CLOPIDOGREL AND PROCESS FOR PREPARATION - Disclosed are new salts of Clopidogrel viz. Clopidogrel mesylate, Clopidogrel besylate and Clopidogrel tosylate, methods for their preparation and pharmaceutical compositions containing them and their use in medicine. | 08-05-2010 |
| 20100204268 | PROCESSES FOR PREPARING DIFFERENT FORMS OF (S)-(+)-CLOPIDOGREL BISULFATE - The invention provides improved processes for the preparation of hydrated form of (S)-(+)-Clopidogrel bisulfate as well as improved processes for the preparation of form-I and form-II of (S)-(+)-Clopidogrel bisulfate. | 08-12-2010 |
| 20100298371 | PROCESS FOR PREPARING CHEMICALLY AND CHIRALLY PURE SOLIFENACIN BASE AND ITS SALTS - The present invention provides improved processes for preparing chemically and chirally pure Solifenacin base. The present invention also provides for a composition comprising of a salt of Solifenacin having at least 98% purity. The present invention also disclose certain new salts of Solifenacin as well as well as new polymorphic forms of Solifenacin hydrochloride and Solifenacin oxalate, in pure form. | 11-25-2010 |
| 20120202988 | PROCESS FOR THE PREPARATION OF RAPAMYCIN DERIVATIVES - The invention relates to processes for the preparation of compound of CCI-779 having the Formula (I), which is useful as an antineoplastic agent. The invention further relates to certain novel intermediates useful in the preparation of compound of CCI-779 and processes for their preparation. The invention also relates to pharmaceutical compositions that include the compound of CCI-779, prepared according to the processes disclosed herein. | 08-09-2012 |
Nitesh Dave, Karnataka IN
| Patent application number | Description | Published |
|---|---|---|
| 20100285143 | ORALLY ADMINISTERABLE SOLID PHARMACEUTICAL COMPOSITION AND A PROCESS THEREOF - The invention relates to improvised pharmaceutical compositions permitting ingestion via oral delivery of proteins/peptides or their conjugates, and/or cation-insulin conjugate complexes demonstrating desirable pharmacokinetic profiles and potency in efficacy models of diabetes in dogs and humans. A preferred formulation comprises 0.01%-20% w/w of insulin, insulin compound conjugates and/or cation insulin conjugates, 10%-60% w/w of one or more fatty acid components selected from saturated or unsaturated C4-C12 fatty acids and/or salts of such fatty acids and additionally contains optimal amounts of other pharmaceutically suitable polymer excipients which permit improved solubility, dissolution rate and effective bioavailability of poorly water soluble compositions and consistent in-vivo release profiles upon scalability during manufacture. A further aspect of the invention features the process of preparing the aforesaid formulations. | 11-11-2010 |
| 20110020871 | Process for the Preparation of Insulin Conjugates - The invention claims a process for making an insulin-oligomer conjugate IN-105. IN-105 precursor having formula G-A-V-R-[B-Chain]-R-D-A-D-D-R-[A-Chain] is cloned and expressed in | 01-27-2011 |
| 20110236925 | Method of Obtaining a Purified, Biologically Active Heterologous Protein - The invention relates to methods of separation and/or purification of impurities yielding a purified heterologous protein product devoid of related impurities or with substantially minimal quantities of such glycosylated impurities. More specifically, the invention relates to the identification of glycosylated forms of insulin analogues such as glargine impurities characterized post expression in yeast based systems such as | 09-29-2011 |
Nitesh Dave, Bangalore IN
| Patent application number | Description | Published |
|---|---|---|
| 20100317827 | Method of Purifying a Peptide - The invention relates, interalia, to the field of purification of peptides, notably cyclic or non-cyclic peptides their analogs or derivatives thereof. More particularly, the invention relates to a simplified and optimized purification process of cyclic peptides from a composition comprising the said peptide and at least one related impurity by chromatographic procedures enabling high yields, selectivity and purity of the desired end product. The improved process is particularly useful for the preparation of eptifibatide, exenatide, atosiban, nesiritide and their respective derivatives and analogs. The polypeptides are prepared in high purity of at least about 96%, and preferably at least about 99%. | 12-16-2010 |
| 20120123089 | PREPARATIVE NON-LINEAR GRADIENT BASED CHROMATOGRAPHIC METHOD AND PURIFIED PRODUCTS THEREOF - The instant disclosure provides a method for purification of peptides by chromatographic techniques. The proposed methodology will help in addressing the problems associated in purifying biological protein products emerging from the evolving biotechnology industry. | 05-17-2012 |
| 20120178900 | CHROMATOGRAPHIC PROCESSES AND PURIFIED COMPOUNDS THEREOF - The present disclosure demonstrates the utility of ion pairing agents in the preparative scale of purification. More particularly, the disclosure relates to the usage of ion pairing agents in RP preparative linear chromatography enabling high purity of the desired end product. The disclosure shows that ion-pairing agents have dramatic effect on desired purity of polypeptides. | 07-12-2012 |
| 20120309935 | METHOD OF REDUCING GLYCOSYLATION OF PROTEINS, PROCESSES AND PROTEINS THEREOF - The disclosure relates to method of reducing O-glycosylation levels of the insulin or insulin analog precursor molecule produced by | 12-06-2012 |
Parthiv Ripudaman Dave, Mumbai IN
| Patent application number | Description | Published |
|---|---|---|
| 20110203991 | CARBON BLOCK FILTER - The present invention relates to a process for making metal impregnated bound Carbon block filters. In particular the present invention to a process for preparing a moulded Carbon block filter impregnated with a metal selected from Silver, Copper or Zinc, with relatively low level of variation in metal content across the blocks, relatively lower deviation from the theoretical metal content, and where the leach-rate of metal from the block during use is relatively low. | 08-25-2011 |
Rachna Dave, Tamil Nadu IN
| Patent application number | Description | Published |
|---|---|---|
| 20090162337 | EMBEDDED ENZYMES IN POLYMERS TO REGULATE THEIR DEGRADATION RATE - A biodegradable material, capable of carrying a bioactive agent, comprising a polymer matrix and an enzyme capable of degrading the polymer matrix to enable the release of the bioactive agent. | 06-25-2009 |
Rohit Harshadrai Dave, Bhavnagar IN
| Patent application number | Description | Published |
|---|---|---|
| 20100172812 | PROCESS FOR THE PREPARATION OF MAGNESIA (MGO) - The present invention provides an improved process for the preparation of MgO of high purity >99% from salt bitterns via intermediate formation of Mg(OH) | 07-08-2010 |
Sanjay K. Dave, Bangalore IN
| Patent application number | Description | Published |
|---|---|---|
| 20120330578 | SEVERITY ANALYSIS APPARATUS AND METHOD FOR SHAFTS OF ROTATING MACHINERY - A method includes receiving one or more vibration signals representing physical vibrations generated by a shaft of a machine during operation. The method also includes determining a rotational speed of the shaft. The method further includes identifying one or more sets of frequency components of the vibration signals based on the speed of the shaft, where each set of frequency components is associated with an operational characteristic of the shaft. In addition, the method includes determining one or more health indicators of the shaft based on relative energy levels of the frequency components in each set of frequency components. | 12-27-2012 |
Sanjay Kantilal Dave, Bangalore IN
| Patent application number | Description | Published |
|---|---|---|
| 20130013086 | DYNAMIC MODEL GENERATION FOR IMPLEMENTING HYBRID LINEAR/NON-LINEAR CONTROLLER - A method of dynamic model selection for hybrid linear/non-linear process control includes developing a plurality of process models including at least one linear process model and at least one non-linear process model from inputs including dynamic process data from a processing system that runs a physical process. At least two of the plurality of process models are selected based on a performance comparison based on at least one metric, wherein the selected process models number less than a number of the plurality of process models received. A multi-model controller is generated that includes the selected process models. The physical process is simulated using the multi-model controller by applying the selected process models to obtain closed loop performance test data for each of the selected models. The performance test data is compared. A selected process model is then selected. | 01-10-2013 |
Saurabh Dave, Bangalore IN
| Patent application number | Description | Published |
|---|---|---|
| 20120284712 | SYSTEMS AND METHODS FOR SR-IOV PASS-THRU VIA AN INTERMEDIARY DEVICE - This disclosure describes a system for Single Root I/O Virtualization (SR-IOV) pass-thru for network packet processing via a virtualized environment of a device. The system includes a device comprising a virtualized environment and a plurality of virtual machines having a virtual network interface for receiving and transmitting network packets. A driver for the physical network interface of the device creates a plurality of virtual devices corresponding to the physical network interface, which appear as a Peripheral Component | 11-08-2012 |